Eagle Bay Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23
| Closed | -$3.2K | – | 179 |
|
|
2024
Q4 | $3.2K | Hold |
23
| – | – | ﹤0.01% | 781 |
|
|
2024
Q3 | $3.47K | Hold |
23
| – | – | ﹤0.01% | 1112 |
|
|
2024
Q2 | $3.17K | Hold |
23
| – | – | ﹤0.01% | 813 |
|
|
2024
Q1 | $3.52K | Hold |
23
| – | – | ﹤0.01% | 801 |
|
|
2023
Q4 | $2.93K | Hold |
23
| – | – | ﹤0.01% | 705 |
|
|
2023
Q3 | $2.18K | Hold |
23
| – | – | ﹤0.01% | 753 |
|
|
2023
Q2 | $2.08K | Buy |
23
+12
| +109% | +$1.08K | ﹤0.01% | 752 |
|
|
2023
Q1 | $1.21K | Hold |
11
| – | – | ﹤0.01% | 803 |
|
|
2022
Q4 | $1.38K | Hold |
11
| – | – | ﹤0.01% | 789 |
|
|
2022
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 794 |
|
|
2022
Q2 | $1.05K | Buy |
+11
| New | +$1.05K | ﹤0.01% | 849 |
|